
Ekaterina Laukhtina
@e_laukhtina
Researcher @MedUni_Wien @Uro_MedUniWien. Member @EAUYAUrology UC Working Group. Editorial Board @wjurol
ID: 1196312908193574913
18-11-2019 06:23:30
307 Tweet
797 Followers
519 Following

In a News and Views now published online, Jakob Klemm, Ekaterina Laukhtina & Shahrokh Shariat discuss a trial of addition of nivolumab to neoadjuvant therapy for muscle-invasive #bladdercancer with results published in Nature Medicine: nature.com/articles/s4157…



Thank you Jeremy Teoh for your inspiring talk! It’s a great honor to have you at the 9th #MJM MedUni Wien Thank you for your friendship #UroSoMe



Excellent mini review Shahrokh F. Shariat Ekaterina Laukhtina Next goal in #BladderCancer👉Bladder Preservation Tasks to work on: ✅Reliable #biomarker/clinical/AI models to predict pT0 ➡️cT0 is not enough ✅Surveillance protocols ✅Adaptive study designs: induction treatment w/wo Cx European Urology


🔝🗓️ We are honored to announce Visiting Professor – Andrew Vickers-> Lectures:“Reforming the Gleason System…” & “Common sense in Research” Get here more information! Join this incredible event in Vienna! ➡️bit.ly/49hJqmE Shahrokh F. Shariat Comprehensive Cancer Center Vienna (CCC) #urology #prostatecancer


CEM24 | MedUni Wien. Come and experience a most amazing meeting that brings together a multinational, multidisciplinary community of urologists, oncologists, radiotherapists, and all other interested specialities. In Vienna, on 26th and 27th April 2024. urologie.meduniwien.ac.at/ueber-uns/even…

3rd meeting of the Vienna-Budapest Urooncologic Research Collaboration #VIBUC Embarking on exciting projects set to transform the field of #urooncology! Nyirády Dr. Péter Shahrokh F. Shariat Tibor Szarvas Ekaterina Laukhtina Bernadett Szabados Urologic Oncology Research MedUni Vienna



Our team #EAU24 👏👏👏 David D'Andrea for Winning the European Association of Urology (EAU) Hans Marberger🏆 with a multicentric RCT on #ERBT vs standard #TURBT EAU Young Urologists Juan Gómez Rivas Marco Moschini Francesco, Del Giudice Ekaterina Laukhtina Benjamin Pradere francesco soria Gautier Marcq Luca Afferi Jose Daniel Subiela Roberto Contieri


Vienna fellowship friendship dinner 🥳#EAU24 Shahrokh F. Shariat Urologic Oncology Research MedUni Vienna Benjamin Pradere Keiichiro Mori Pawel Rajwa Tamas Fazekas MD Fahad Quhal فهد قحل MPallauf Nico Grossmann Takafumi Yanagisawa Tatsushi Kawada Marcin Ch



Online now: Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive #BladderCancer Ekaterina Laukhtina et al doi.org/10.1111/bju.16…


Amazing talks on antibody-drug conjugates and bladder-sparing strategies in #bladdercancer by Bernadett Szabados Barts Experimental Cancer Medicine Centre UCLH and Ekaterina Laukhtina Urologic Oncology Research MedUni Vienna Tamas Fazekas MD


Clinical Validation of the Intermediate-risk NMIBC Scoring System and Substratification Model Proposed by the IBCG (International Bladder Cancer Group): A Multicenter YAU Urothelial Working Group Collaboration European Urology Oncology Paolo Gontero francesco soria authors.elsevier.com/c/1jIAG9Cfv--d… a🧵


Breaking the stereotypes! Finally our study on en bloc #ERBT for large tumours (>3 cm) is online in Minerva Urology and Nephrology. Conclusion: it is feasible, effective and safe. Andrey Morozov Vladislav Petov Ekaterina Laukhtina Jeremy Teoh nirm Thomas RW Herrmann Shahrokh F. Shariat minervamedica.it/en/journals/mi…




It’s a pleasure to monitor how young researcher from EAU YAU Urothelial Carcinoma is becoming well known 🌍 expert in field. Ekaterina Laukhtina sheds some light on risk stratification of NMIBC in MedUni Wien during BCa master class 10th MJM meeting.

